Seeing the Forest Through the Trees:
Therapeutic Approaches for Hospitalized Patients with COVID-19

Tweetorial #1: Severity Assessments

Certification period for this program has expired. No credit will be offered beyond the program dates noted on the bottom of this page.


This activity is jointly provided by National Jewish Health (NJH) and Bonum CE.

This program has been supported by an independent educational grant from Gilead Sciences, Inc.

Program Overview

The mortality rate for COVID-19 remains high, especially in older patients and those with comorbidities. The aim of this proposed educational initiative is to improve the familiarity of hospitalists and other healthcare professionals (HCPs) involved in the treatment of hospitalized patients with COVID-19 regarding updated guidelines, rationale for the use of therapeutic agents in different disease stages, and up-to-date clinical safety and efficacy data for approved and emerging COVID-19 drugs.

This CME-certified, Tweetorial reviews the latest clinical guidance regarding severity assessments and informs HCPs of staging options for hospitalized patients with COVID-19.

Faculty

Onyema Ogbuagu, MD (co-chair)
Associate Professor of Medicine
Director, Antivirals and Vaccines Research Program, Yale AIDS Program
Section of Infectious Diseases
Yale University School of Medicine
New Haven, CT

Nida Qadir, MD (co-chair)
Associate Clinical Professor
Department of Medicine
Division of Pulmonary & Critical Care Medicine
David Geffen School of Medicine
UCLA
Los Angeles, CA

Charles Wray, DO, MS, FHM (co-chair)
Associate Professor of Medicine
Department of Medicine
University of California, San Francisco
HSR Investigator & Hospital Educator
San Francisco VA Medical Center
San Francisco, CA

Target Audience

  • Physicians, NPs, PAs in the following specialties: Hospitalists, Pulmonologists, Internal Medicine, Emergency Medicine, Urgent Care, Infectious Disease

  • Clinical pharmacists, nurses, and other HCPs involved in the care and management of patients with COVID-19

Learning Objectives

Upon completion of this educational activity, participants will be able to:

  • Select the appropriate treatment regimen depending on the COVID-19 disease stage according to the most recent guidelines

Disclosure of Relevant Financial Relationships

In accordance with the Accreditation Council for Continuing Medical Education (ACCME), National Jewish Health requires that all program faculty, content developers, reviewers, and others in a position to control the content of this activity disclose to learners the presence or absence of any relevant financial relationships with an ACCME-defined ineligible company within the preceding 24 months of the activity. The ACCME defines an “ineligible company” as one whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Our goal is to ensure that there is no compromise in the ethical relationship that exists between those in a position to control the content of the activity and those participating in the activity and their respective professional duties. All accredited education activities offered by National Jewish Health are reviewed to ensure a balanced and evidence-based presentation.

All relevant financial relationships among individuals in a position to control the content of this activity have been identified and mitigated according to the Standards of Integrity and Independence in Accredited Continuing Education.

 

  • Onyema Ogbuagu, MD
    Advisory Board: Gilead Sciences, Janssen, ViiV
    Speaker’s Bureau: Gilead Sciences

    Nida Qadir, MD
    Nothing to disclose

    Charles Wray, DO, MS, FHM
    Nothing to disclose

  • Zulma Yunt, MD
    Nothing to disclose

  • National Jewish Health and Bonum CE staff and others involved with the planning, development, and review of the content for this activity have no relevant financial relationships to disclose.

Certification

Physician Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of National Jewish Health and Bonum Continuing Education, LLC.  National Jewish Health is accredited by the ACCME to provide continuing medical education for physicians.

Physician Credit Designation
National Jewish Health designates this Other activity (social media presentation) for a maximum of 0.25 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

European Physicians
The American Medical Association has an agreement of mutual recognition of Continuing Medical Education (CME) credits with the European Union of Medical Specialists (UEMS), the accreditation body for European countries. Physicians interested in converting AMA PRA Category 1 Credit™ to UEMS-European Accreditation Council for Continuing Medical Education CME credits (ECMEC®s) should contact the UEMS at mutualrecognition@uems.eu.

Instructions to Receive Credit & Fee Information

In order to receive credit for this activity, the participant must read the front matter, achieve a passing score of 75% on the post-test, complete the evaluation and application for credit form.

There is no fee to participate in this activity.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. National Jewish Health, collaborators, and faculty on this program do not recommend the use of any agent outside of the labeled indications. 

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimers

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

System Requirements

All Bonum CE digital activities require the following hardware/software to view and participate:

  • Internet connection (via PC or Mac desktop or laptop computer, tablet, mobile device, etc.)

  • PowerPoint and/or a PDF viewer may be required on some activities

We recommend a minimum of:

  • 128MB RAM

  • Processor speed of 500MHz or higher

  • 800x600 color monitor

  • Video or graphics card

  • Sound card and speakers

To actively participate in Bonum’s social media (SoMe)-based CME programs, learners will need to have an established account in good standing on that hosting SoMe site. Learners will need to be logged-in to the SoMe hosting platform.

Contact Information

For information about the accreditation of this program, please contact the Office of Professional Education at National Jewish Health at proed@njhealth.org.

Release date: March 16, 2023
Expiration date: March 16, 2024
Estimated time to complete activity: 15 minutes